Skip to main content

Table 2 Cardiac parameters of the study population subdivided according to the presence or the absence of Metabolic syndrome and Hyperhomocysteinemia

From: Hyperhomocysteinemia accompany with metabolic syndrome increase the risk of left ventricular hypertrophy in rural Chinese

 MetS (−)MetS (+)
HHcy (−)HHcy (+)HHcy (−)HHcy (+)
End-diastolic LV internal dimension(mm)4.61 ± 0.414.74 ± 0.43*4.72 ± 0.42*4.85 ± 0.44*#^
End-diastolic posterior wall thickness(mm)0.83 ± 0.080.86 ± 0.11*0.88 ± 0.12*#0.90 ± 0.11*#^
End-diastolic interventricular septum(mm)0.85 ± 0.110.89 ± 0.15*0.90 ± 0.12*#0.94 ± 0.14*#^
LV mass(g)144.60 ± 38.59162.44 ± 47.21*165.74 ± 47.11*#181.69 ± 50.27*#^
LV mass indexed for BSA(gm−2)90.93 ± 22.2799.19 ± 26.93*98.77 ± 26.92*105.01 ± 28.06*#^
LV mass indexed for height2.7(gm-2.7)40.96 ± 10.9343.78 ± 13.10*47.96 ± 13.94*#49.77 ± 14.21*#^
Ejection fraction63.39 ± 3.9862.667 ± 4.21*63.16 ± 3.91#62.54 ± 4.42*^
  1. Abbreviations: LV left ventricular, MetS metabolic syndrome. * vs. MetS (−) + HHcy (−), P < 0.05; # vs. MetS (−) + HHcy (+), P < 0.05; ^ vs. MetS (+) + HHcy (−), P < 0.05;